Australia challenges Nurofen painkiller
Sydney
AUSTRALIA'S consumer watchdog has launched court action against drug giant Reckitt Benckiser, alleging false or misleading claims about its popular painkiller Nurofen.
However, the brand disputed the allegations and said its range of painkillers complied with Australian guidelines. The Australian Competition and Consumer Commission said last week that Nurofen's products claim on packaging, and its website, to be formulated to treat different types of pain, when the main ingredient is the same.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Holiday Inn owner IHG’s Q1 revenue up 2.6%, leisure travel demand remains strong
WSJ moves Asia headquarters from Hong Kong to Singapore
South Korea to slap fines on food suppliers for ‘shrinkflation’
Olam outbids Dreyfus’ sweetened deal for Australia’s Namoi, raises offer to A$0.66 per share
Live Nation’s revenue beats estimates as boom in concerts drive ticket sales
Jim Beam owner bets on canned vodka cocktails to double revenue